Pitches

Regulatory Perspectives: Essential Requirements and Considerations (e.g. PARC and KeyAreas of Regulatory Challenges)
Mike Rasenberg, ECHA

Member state perspective: relevance of test method to prevent adverse effects human health and the environment
Thomas Kuhlbusch, Federal Institute of Occupational Safety and Health

Commission perspective on EU test method and validation strategy
Katrin Schutte, European Commission DG ENV & Georg Streck, European Commission DG GROW

End-user Perspectives: Essential Requirements and Considerations
Susanne Kolle, BASF

The benefits of mutual acceptance of data (cost saving of repeating tests, having a clear framework, MS responsibilities)
Anne Gourmelon, OECD

Collaborative Public-Private Platform for Pre-Validation of Endocrine Disruptor Characterization Methods: A Stakeholder Partnership Example
Philippe Hubert, PEPPER

Scientific activities related to development and validation of new methods and approaches
Tom van Teunenbroek (retired, Dutch Ministry of Infrastructure and Water Management)